Peptide derivative, pharmaceutically acceptable salt thereof, process for producing the same, and use thereof

Details for Australian Patent Application No. 2002343783 (hide)

Owner Taiho Pharmaceutical Co., Ltd.

Inventors Yamamoto, Kenji; Asao, Tetsuji; Suda, Yoshimitsu

Agent Pizzeys

Pub. Number AU-B-2002343783

PCT Number PCT/JP02/11860

PCT Pub. Number WO2003/042237

Priority 2001-352012 16.11.01 JP

Filing date 14 November 2002

Wipo publication date 26 May 2003

Acceptance publication date 18 January 2007

International Classifications

C07K 5/02 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

C07C 279/36 (2006.01) Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

27 February 2003 Complete Application Filed

  Priority application(s): 2001-352012 16.11.01 JP

24 July 2003 Application Open to Public Inspection

  Published as AU-B-2002343783

18 January 2007 Application Accepted

  Published as AU-B-2002343783

17 May 2007 Standard Patent Sealed

31 July 2008 Assignment Registered

  Taiho Pharmaceutical Co., Ltd. The patent has been assigned to Kyushu University, National University Corporation

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002343784-Crystalline polyglycolic acid, polyglycolic acid composition and production process thereof

2002343782-Water jet propelling device of boat